FDA fines Globus Medical and CEO $1M for selling rejected bone graft products (MassDevice)
Orthopedics device maker Globus Medical and its CEO agree to pay a $1 million fine after an FDA inspection finds the company marketing bone graft products that the agency had denied for the U.S. market.
Orthopedics device maker Globus Medical will pay $1 million, including a fine for its chief officer, to settle FDA charges that the company marketed bone graft products without getting the agency's approval.
The fine includes $550,000 in penalties and a $450,000 charge for Globus CEO David Paul.
"Firm...
The Orthopedics Industry 
